Diametric Capital’s Medpace MEDP Stock Holding History

Diametric Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-458	Closed	-$235K	–	444
2025 Q3	$235K	Buy	+458	New	+$200K	0.09%	289
2023 Q3	–	Sell	-1,245	Closed	-$299K	–	393
2023 Q2	$299K	Buy	+1,245	New	+$259K	0.13%	202

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Diametric Capital's MEDP Position: Q4 2025 in Review

Diametric Capital sold out of Medpace (MEDP) in Q4 2025, closing a stake of 458 shares — an estimated $235K sold.

Diametric Capital first reported a position in MEDP in Q2 2023 and held it in 2 quarters. The position peaked at $299K in Q2 2023. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

Diametric Capital reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
Diametric Capital sold 458 Medpace shares in Q4 2025, an estimated $235K.
Diametric Capital first reported a position in Medpace in Q2 2023 and held it in 2 quarters.
Diametric Capital's Medpace position peaked at $299K in Q2 2023.
785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Diametric Capital's 13F filing for Q4 2025, filed 13 Feb 2026.